|
« Factbook Table of
Contents
6. Institute Public Advisory Committees
National Heart, Lung, and Blood
Advisory Council
Structure
Chair: Elizabeth G. Nabel, M.D.,
Director, NHLBI
Executive Secretary: Stephen C.
Mockrin, Ph.D., Director, Division of Extramural Research Activities, NHLBI,
National Institutes of Health, Bethesda, MD 20892; 301–435–0260
The Secretary of HHS appoints 18 members: 12 members
are leading representatives of the health and scientific disciplines (including
public health and behavioral or social sciences), and 6 are from the general
public and are leaders in the fields of public policy, law, health policy,
economics, and management.
Members are appointed for overlapping terms of 4
years.
The Council includes the following ex officio
members:
- Secretary, HHS
- Director, NIH
- Director, NHLBI
- Chief Medical Director, or Designee, Veterans
Affairs
- Assistant Secretary of Defense for Health Affairs,
or Designee.
Functions
The NHLBAC reviews applications for research grants,
cooperative agreements, and training grants in heart, blood vessel, lung, and
blood diseases; sleep disorders; and blood resources, and recommends scientific
projects that merit support to the Director, NHLBI.
The Council advises the Secretary, HHS, the Assistant
Secretary for Health, HHS, and the Directors, NIH and NHLBI, on matters
relating to causes, prevention, diagnosis, and treatment of diseases and
resources within the purview of the Institute. The Council also may review any
grant, contract, or cooperative agreement proposed to be made or entered into
by the Institute; may make recommendations to the Director of the Institute
respecting research conducted at the Institute; may collect, by correspondence
or by personal investigation, information as to studies that are being carried
on in the United States or any other country with respect to the cause,
prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood
diseases, and to the use of blood and blood products and the management of
blood resources and with the approval of the Director of the Institute, make
available such information through appropriate publications for the benefit of
public and private health entities and health professions personnel and
scientists and for the information of the general public; and may assemble ad
hoc working groups, appoint subcommittees, and convene workshops and
conferences.
The Council may also make recommendations to the
Director, NIH and other authorized officials regarding the acceptance of
conditional gifts pursuant to section 231 of the Public Health Service Act, as
amended.
Meetings
The Chair convenes meetings not fewer than four times
a year and approves the agenda.
National Heart, Lung, and Blood Advisory Council
Membership*
Elizabeth G. Nabel, M.D.
Chair
National Heart, Lung, and Blood Institute
Jeanine Arden Ornt, J.D. (2010)
Case Western
Reserve University
C. Noel Bairey Merz, M.D. (2011)
Cedars-Sinai
Medical Center
Shaun R. Coughlin, M.D., Ph.D. (2010)
University
of California, San Francisco
Victor J. Dzau, M.D. (2009)
Duke University
Charles T. Esmon, Ph.D. (2008)
Oklahoma Medical
Research Foundation
Joe G. N. Garcia, M.D. (2010)
University of
Chicago
Katherine A. High, M.D. (2008)
University of
Pennsylvania School of Medicine
Helen H. Hobbs, M.D. (2009)
University of Texas
Southwestern Medical Center
Jennie R. Joe, Ph.D. (2009)
University of
Arizona
J. Hoxi Jones (2008)
Texas Health and Human
Services Commission
Joseph Loscalzo, M.D., Ph.D. (2009)
Brigham and
Women’s Hospital
Andrew R. Marks, M.D. (2011)
Columbia
University
Jeffrey McCullough, M.D. (2008)
University of
Minnesota
S. K. Rao Musunuru, M.D. (2010)
Bayonet
Point/Hudson Cardiology Associates
Paula Y. Polite (2010)
Division of General
Services, Memphis
Marlene Rabinovitch, M.D. (2011)
Stanford
University
Steven D. Shapiro, M.D. (2010)
University of
Pittsburgh
Patricia W. Wahl, Ph.D. (2008)
University of
Washington
Ex Officio Members
Robert L. Jesse, M.D., Ph.D.
McGuire Veterans
Affairs Medical Center
Michael O. Leavett
Department of Health and Human
Services
Cdr. Richard T. Mahon, M.D.
Naval Medical Research
Center
Elias A. Zerhouni, Jr., M.D.
National Institutes
of Health
Back to Top
Program Advisory and Review
Committee
Sickle Cell Disease Advisory
Committee
Chair: Vacant
Executive Secretary: Harvey S.
Luksenburg, Ph.D., Health Scientist Administrator, Division of Blood Diseases
and Resources, NHLBI, National Institutes of Health, Bethesda, MD 20892;
301–435–0050
The Sickle Cell Disease Advisory Committee advises the
Secretary and the Assistant Secretary for Health, HHS and the Directors of the
NIH, the NHLBI, and the DBDR on matters related to the Sickle Cell Disease
Program and makes recommendations concerning planning, execution, and
evaluation of all aspects of the program.
Membership*
Michael A. Bender, M.D., Ph.D. (2010)
Fred
Hutchinson Cancer Research Center
Punam Malik, M.D. (2010)
Cincinnati
Children’s Hospital Medical Center
Susan P. Perrine, M.D. (2011)
Boston
University
Yogen Saunthararajah, M.D. (2011)
Cleveland
Clinic
Wally R. Smith, M.D. (2011)
Virginia Commonwealth
University
Ex Officio Members
Joseph Desimone, Ph.D.
Department of Veterans
Affairs, Chicago
Marie Y. Mann, M.D.
Health Resources and Services
Administration
David E. McCune, M.D.
Madigan Army Medical
Center
Elias A. Zerhouni, Jr., M.D.
National Institutes
of Health
Sleep Disorders Research Advisory
Board
Chair: Phyllis C. Zee, M.D., Ph.D.,
Northwestern University Medical School
Executive Secretary: Michael J.
Twery, Ph.D., Director, National Center on Sleep Disorders Research, NHLBI,
National Institutes of Health, Bethesda, MD 20892; 301–435–0202.
The Sleep Disorders Research Advisory Board advises
the Directors of the NIH, the NHLBI, and the NCSDR on matters related to the
scientific activities carried out by and through the Center and policies
regarding such activities, including the identification of research priorities
for coordination of sleep and sleep disorders research by the NIH and other
Federal, professional, and voluntary organizations.
Membership*
Sonia Ancoli-Israel, Ph.D. (2010)
University of
California, San Diego School of Medicine
Rose A. Austin (2011)
SSM Healthcare
Karen M. Cushing (2011)
American Insomnia
Association
Charles A. Czeisler M.D., Ph.D. (2011)
Harvard
Medical School
Estelle B. Gauda, M.D. (2010)
Johns Hopkins
University School of Medicine
F. Javier Nieto, M.D., Ph.D. (2010)
University of
Wisconsin School of Medicine
Howard P. Roffwarg, M.D. (2009)
University of
Mississippi Medical Center
Robert H. Waterman (2011)
The Waterman Group
Back to Top
Ex Officio Members
Thomas J. Balkin, Ph.D.
Walter Reed Army Institute
of Research
Robert W. Greene, M.D., Ph.D.
Veterans
Administration, North Texas Medical Center
Merrill M. Mitler, Ph.D.
NINDS, National
Institutes of Health
Andrew Monjan, Ph.D.
NIA, National Institutes of
Health
Elizabeth G. Nabel, M.D.
NHLBI, National
Institutes of Health
Michael J. Twery, Ph.D.
NCSDR, National Institutes
of Health
Marian Willinger, Ph.D.
NICHD, National Institutes
of Health
Elias A. Zerhouni, Jr., M.D.
National Institutes
of Health
Heart, Lung, and Blood Initial
Review Group
Scientific Review Officer: Jeffery H.
Hurst, Ph.D., Health Science Administrator, Division of Extramural Research
Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892;
301–435–0303
The Heart, Lung, and Blood Initial Review Group
provides initial technical merit review for the NHLBAC and the Director, NHLBI.
This group consists of three subcommittees: the Heart, Lung, and Blood Program
Project Review Committee, the Clinical Trials Review Committee, and the NHLBI
Institutional Training Mechanism Review Committee.
Heart, Lung, and Blood Program
Project Review Committee
Chair: Susan S. Smyth, M.D., Ph.D.,
The Gill Heart Institute
Scientific Review Officer: Jeffery H.
Hurst, Ph.D., Health Scientist Administrator, Division of Extramural Research
Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892;
301–435–0303
The Heart, Lung, and Blood Program Project Review
Committee provides initial technical merit review for the NHLBAC and the
Director, NHLBI on program project applications proposing research in the areas
of heart, lung, and blood diseases and resources.
Membership*
Edward Abraham, M.D. (2009)
University of Alabama
at Birmingham
David Atkinson, Ph.D. (2012)
Boston University
School of Medicine
Karen E. Bornfeldt, Ph.D. (2011)
University of
Washington
Peng-Sheng Chen, M.D. (2010)
Indiana University
School of Medicine
Samuel Hawgood, M.D. (2010)
University of
California, San Francisco
Catherine C. Hedrick, Ph.D. (2011)
University of
Virginia
Sriram Krishnaswamy, Ph.D. (2009)
Children’s
Hospital of Philadelphia
Christine S. Moravec, Ph.D. (2012)
Cleveland
Clinic Foundation
Diane J. Nugent, M.D. (2009)
University of
California, Los Angeles
David J. Pinsky, M.D. (2012)
University of
Michigan
Bruce R. Pitt, Ph.D. (2009)
University of
Pittsburgh
Nanduri R. Prabhakar, Ph.D. (2012)
University of
Chicago
Ann Marie Schmidt, M.D., Ph.D. (2010)
Columbia
University
Back to Top
Curt D. Sigmund, Ph.D. (2011)
University of
Iowa
Arun Srivastava, Ph.D. (2011)
University of
Florida
Robert A. Wise, M.D. (2010)
Johns Hopkins
University School of Medicine
Katherine E. Yutzey, Ph.D. (2010)
Children’s
Hospital Research Foundation
Clinical Trials Review
Committee
Chair: Vacant
Scientific Review Officer: Keary A.
Cope, Ph.D., Health Science Administrator, Division of Extramural Research
Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892;
301–435–2222
The Clinical Trials Review Committee provides initial
technical merit review for the NHLBAC and the Director of the NHLBI on clinical
trial applications for the support of studies to evaluate preventive or
therapeutic measures of blood, cardiovascular, or lung diseases.
Membership*
Walter T. Ambrosius, Ph.D. (2010)
Wake Forest
University
Ulrika M. Birgersdotter-Green, M.D. (2009)
University of California, San Diego
Ivan Chan, Ph.D. (2010)
Merck Research
Laboratories
Scott S. Emerson, M.D., Ph.D. (2011)
University of
Washington
Kenneth E. Freedland, Ph.D. (2011)
Washington
University School of Medicine
Terry B. Gernsheimer, M.D. (2009)
University of
Washington School of Medicine
Robert A. Harrington, M.D. (2010)
Duke School of
Medicine
Wendy J. Mack, Ph.D. (2011)
University of Southern
California
Pamela Ouyang, M.D. (2010)
Johns Hopkins
University School of Medicine
John J. Reilly, M.D. (2009)
Brigham and
Women’s Hospital
Back to Top
NHLBI Institutional Training
Mechanism Review Committee
Chair: William C. Balke, M.D.,
University of Kentucky
Scientific Review Officer: Charles
Joyce, Ph.D., Health Science Administrator, Division of Extramural Research
Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892;
301–435–0291
NHLBI Institutional Training Mechanism Review
Committee provides initial technical merit review for the NHLBAC and the
Director of the NHLBI on training applications that provide predoctoral,
postdoctoral, and short-term research training at academic institutions.
Membership*
Ifeanyi J. Arinze, Ph.D. (2012)
Meharry Medical
College
Linda J. Burns, M.D. (2011)
University of
Minnesota
David M. Center, M.D. (2011)
Boston University
Medical Campus
David M. Guidot, M.D. (2010)
Emory University
Meredith Hay, Ph.D. (2009)
University of Iowa
Carlton A. Hornung, Ph.D. (2010)
University of
Louisville
Mariell Jessup, M.D. (2009)
University of
Pennsylvania Health System
Back to Top
Craig K. Kent, M.D. (2010)
Weill Medical College
of Cornell University
Bertram H. Lubin, M.D. (2010)
Children’s
Hospital Oakland Research Institute
Russell V. Luepker, M.D. (2012)
University of
Minnesota
Jonathan C. Makielski, M.D. (2012)
University of
Wisconsin Hospitals and Clinics
Fernando J. Martinez, M.D. (2009)
University of
Michigan at Ann Arbor
Josef T. Prchal, M.D. (2012)
University of
Utah
Sharon Rounds, M.D. (2010)
Brown University
Robin Shandas, Ph.D. (2012)
University of Colorado
Health Sciences Center
Sanjeev G. Shroff, Ph.D. (2010)
University of
Pittsburgh
Brian Smith, M.D. (2011)
Yale University School of
Medicine
Marilyn J. Telen, M.D. (2009)
Duke University
Medical Center
Mary I. Townsley, Ph.D. (2012)
University of South
Alabama
Donna H. Wang, M.D. (2011)
Michigan State
University
Scott T. Weiss, M.D. (2011)
Brigham and
Women’s Hospital
Marlys H. Witte, M.D. (2009)
University of
Arizona, Health Sciences Center
Reen Wu, Ph.D. (2011)
University of California at
Davis
Back to Top
National Heart, Lung, and Blood Institute Special
Emphasis Panel
The Institute has established the NHLBI Special
Emphasis Panel (SEP) to perform initial peer review of applications and
proposals that were previously handled by ad hoc committees. Concept review,
previously handled by divisional program advisory committees, has also been
incorporated into the SEP system. The SEP, which has neither a fixed membership
nor a set meeting schedule, is constituted to provide required peer review
expertise at precisely the time that it is needed.
Board of Scientific Counselors
Chair: Gary K. Owens, M.D., Ph.D.,
University of Virginia School of Medicine
Executive Secretary: Robert S. Balaban, Ph.D.,
Director, Laboratory Research Program, NHLBI, National Institutes of Health,
Bethesda, MD 20892; 301–496–2116
The Board of Scientific Counselors advises the
Director and the Deputy Director for Intramural Research, NIH, and the
Directors of NHLBI and the Division of Intramural Research, NHLBI, on the
intramural research programs of the NHLBI.
Membership*
Stephen Black, Ph.D. (2011)
Medical College of
Georgia
Eduardo Marban, M.D., Ph.D. (2011)
Johns Hopkins
University
Elizabeth M. McNally, M.D., Ph.D. (2010)
University of Chicago
Edwin W. Taylor, Ph.D. (2009)
University of
Chicago
Alan S. Verkman, M.D., Ph.D. (2009)
University of
California, San Francisco * Current as of October 2008. The current roster,
containing full addresses for the NHLBI Advisory Council and Committees, can be
obtained from the Internet at
http://www.nhlbi.nih.gov/meetings/nhlbac/roster.htm.
Back to Top
« Factbook Table of
Contents
|
Get Email Alerts
Font Size
Twitter
Facebook
YouTube
Google+